← Back to Search
Pharmacokinetics Of Nanomaterials: An Overview Of Carbon Nanotubes, Fullerenes And Quantum Dots.
Published 2009 · Materials Science, Medicine
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
A full understanding of the pharmacokinetic parameters describing nanomaterial disposition in the body would greatly facilitate development of a firm foundation upon which risk assessment could be based. This review focuses on the disposition of carbon based fullerenes and nanotubes, as well as quantum dots (QD) after parenteral administration to primarily rodents. The common theme across all particle types is that a major determinant of nanomaterial disposition is the degree of interaction with the reticuloendothelial (RE) cell system. Small water-soluble particles evading this system may be excreted by the kidney. Larger particles and those with the proper surface charge may get targeted to RE cells in the liver, spleen and other organs. Most nanomaterial kinetics are characterized by relatively short blood half-lives reflecting tissue extraction and not by clearance from the body. In fact, another common attribute to nanomaterial kinetics is retention of particles in the body. Finally, unlike many small organic drugs, nanomaterials may preferentially be trafficked in the body via the lymphatic system that has obvious immunological implications.
This paper references
Definition of a physiologic pharmacokinetic model of cutaneous drug distribution using the isolated perfused porcine skin flap.
P. L. Williams (1989)
In vivo biological behavior of a water-miscible fullerene: 14C labeling, absorption, distribution, excretion and acute toxicity.
S. Yamago (1995)
Tissue Sites of Uptake of14C-Labeled C60
Rebecca Bullard-Dillard (1996)
Pharmacokinetics of a water-soluble fullerene in rats
P. Rajagopalan (1996)
Comparative Pharmacokinetics: Principles, Techniques, and Applications
J. Riviere (1999)
In vivo studies of fullerene-based materials using endohedral metallofullerene radiotracers.
D. W. Cagle (1999)
Lymphatic targeting with nanoparticulate system.
Y. Nishioka (2001)
Lymphatic transport of proteins after s.c. injection: implications of animal model selection.
C. J. Porter (2001)
TRANSLOCATION OF ULTRAFINE INSOLUBLE IRIDIUM PARTICLES FROM LUNG EPITHELIUM TO EXTRAPULMONARY ORGANS IS SIZE DEPENDENT BUT VERY LOW
W. Kreyling (2002)
Nanocrystal targeting in vivo
M. Akerman (2002)
Preparation of (99m)Tc-C(60)(OH)(x) and its biodistribution studies.
Li Qingnuan (2002)
In Vitro and In Vivo Study of Solid Lipid Nanoparticles Loaded with Superparamagnetic Iron Oxide
E. Peira (2003)
Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping
S. Kim (2004)
Noninvasive imaging of quantum dots in mice.
B. Ballou (2004)
Pharmacokinetic Model to Describe the Lymphatic Absorption of r-metHu-Leptin After Subcutaneous Injection to Sheep
Danielle N. McLennan (2004)
Intraoperative sentinel lymph node mapping of the lung using near-infrared fluorescent quantum dots.
E. Soltesz (2005)
Lymphatic Absorption Is the Primary Contributor to the Systemic Availability of Epoetin Alfa following Subcutaneous Administration to Sheep
Danielle N. McLennan (2005)
Biodistribution and tumor uptake of C60(OH)x in mice
Z. Ji (2006)
Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers.
R. Singh (2006)
Mammalian pharmacokinetics of carbon nanotubes using intrinsic near-infrared fluorescence
P. Cherukuri (2006)
Pharmacokinetics of Nanoscale Quantum Dots: In Vivo Distribution, Sequestration, and Clearance in the Rat†
H. Fischer (2006)
Health implications of nanoparticles
W. Kreyling (2006)
microPET-Based Biodistribution of Quantum Dots in Living Mice
M. L. Schipper (2007)
Persistent Tissue Kinetics and Redistribution of Nanoparticles, Quantum Dot 705, in Mice: ICP-MS Quantitative Assessment
R. Yang (2007)
Carbon nanomaterials in biological systems
P. Ke (2007)
Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models.
L. Balogh (2007)
Pharmacometrics : the science of quantitative pharmacology
E. Ette (2007)
Biodistribution of quantum dot nanoparticles in perfused skin: evidence of coating dependency and periodicity in arterial extraction.
H. A. Lee (2007)
Migration of intradermally injected quantum dots to sentinel organs in mice.
N. Gopee (2007)
Biodistribution of functionalized multiwall carbon nanotubes in mice.
Jin-xue Guo (2007)
In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice.
Z. Liu (2007)
Role of nanotechnology in pharmaceutical product development.
H. Devalapally (2007)
Translocation and fate of multi-walled carbon nanotubes in vivo
Xiaoyong Deng (2007)
Renal clearance of quantum dots
H. Choi (2007)
Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials.
D. Dutta (2007)
Pharmacokinetics of Nanomaterials
J. Riviere (2007)
Nanoscaled carriers: nanomedicine for the improved delivery of drugs across biological barriers
CM Lehr (2007)
Bioconjugated quantum rods as targeted probes for efficient transmigration across an in vitro blood-brain barrier.
G. Xu (2008)
This paper is referenced by
Synergic effects of nanoparticles-mediated hyperthermia in radiotherapy/chemotherapy of cancer.
K. Mortezaee (2021)
Carbon Nanotubes—Potential of Use for Deep Bioimaging
Atsuto Onoda (2021)
Transparency in Biology: Making the Invisible Visible
K. Soga (2021)
Water-Soluble Carbon Dots in Cigarette Mainstream Smoke: Their Properties and the Behavioural, Neuroendocrinological, and Neurotransmitter Changes They Induce in Mice
Yan Zhao (2021)
Evaluation of the Biodistribution of Serinolamide-Derivatized C60 Fullerene
Nicholas G Zaibaq (2020)
Safe Administration of Carbon Nanotubes by Intravenous Pathway in BALB/c Mice
José Jesús Guzmán-Mendoza (2020)
Nanomaterial Additives for Fabrication of Stimuli-Responsive Skeletal Muscle Tissue Engineering Constructs.
Amy Corbin Farr (2020)
An in-silico layer-by-layer adsorption study of the interaction between Rebaudioside A and the T1R2 human sweet taste receptor: modelling and biosensing perspectives
Olayide A. Arodola (2020)
Eco-friendly and sustainable synthesis of biocompatible nanomaterials for diagnostic imaging: current challenges and future perspectives
Ghazaleh Jamalipour Soufi (2020)
Disposition of fullerene C60 in rats following intratracheal or intravenous administration
K. Shipkowski (2019)
Translating Nanomedicine to Comparative Oncology—the Case for Combining Zinc Oxide Nanomaterials with Nucleic Acid Therapeutic and Protein Delivery for Treating Metastatic Cancer
R. DeLong (2019)
Nonspecific nanocarriers for doxorubicin and cytarabine in the presence of fatted and defatted human albumin. Part I
D. Pentak (2019)
Kinetic profile of silver and zinc oxide nanoparticles by intraperitoneal injection in mice , a comparative study
Sarab Mohammed M. Razooki (2019)
Application of Bayesian networks in determining nanoparticle-induced cellular outcomes using transcriptomics
I. Furxhi (2019)
Modeling gold nanoparticle biodistribution after arterial infusion into perfused tissue: effects of surface coating, size and protein corona
J. Riviere (2018)
Emerging investigator series: the dynamics of particle size distributions need to be accounted for in bioavailability modelling of nanoparticles
M. Vijver (2018)
Nano- and neurotoxicology: An emerging discipline
A. Bencsik (2018)
An assessment of applicability of existing approaches to predicting the bioaccumulation of conventional substances in nanomaterials.
W. Utembe (2018)
Biokinetics of Nanomaterials: the Role of Biopersistence.
P. Laux (2017)
Protein corona modulation of hepatocyte uptake and molecular mechanisms of gold nanoparticle toxicity
K. Choi (2017)
Computational approaches and metrics required for formulating biologically realistic nanomaterial pharmacokinetic models
E. Burello (2017)
The Safety of Nanomaterials on Molecular and Cellular Scale
A. Kraegeloh (2017)
Biocorona formation on gold nanoparticles modulates human proximal tubule kidney cell uptake, cytotoxicity and gene expression.
M. T. Ortega (2017)
Generation and characterization of aerosols released from sanding composite nanomaterials containing carbon nanotubes
J. Kang (2017)
Carbon Nanotubes in Targeting and Delivery of Drugs
Rakesh K Tekade (2017)
A comprehensive framework for evaluating the environmental health and safety implications of engineered nanomaterials
W. Boyes (2017)
A Bayesian Regression Methodology for Correlating Noisy Hazard and Structural Alert Parameters of Nanomaterials
Eamonn M. McAlea (2016)
Biodistribution and Pharmacokinetics of Carbon Nanomaterials In Vivo
Sheng-Tao Yang (2016)
A physiologically based pharmacokinetic model for polyethylene glycol-coated gold nanoparticles of different sizes in adult mice
Z. Lin (2016)
Systemic distribution of single-walled carbon nanotubes in a novel model: alteration of biochemical parameters, metabolic functions, liver accumulation, and inflammation in vivo
Elisa Principi (2016)
Frameworks and tools for risk assessment of manufactured nanomaterials.
D. Hristozov (2016)
Carbon Nanostructures in Bone Tissue Engineering
B. Perkins (2016)See more